United States Ophthalmic Drug Industry 2016 Deep Market Research Report
- QYR609629
- 130 Pages
- June 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Ophthalmic Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Ophthalmic Drug industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 153 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Ophthalmic Drug
1.1.1 Definition of Ophthalmic Drug
1.1.2 Specifications of Ophthalmic Drug
1.2 Classification of Ophthalmic Drug
1.2.1 Lucentis
1.2.2 Eylea
1.2.3 Restasis
1.2.4 Vigamox
1.2.5 Pataday/ Patanol
1.2.6 Jetrea
1.2.7 Lumigan and Ganfort
1.3 Applications of Ophthalmic Drug
1.4 Industry Chain Structure of Ophthalmic Drug
1.5 Industry Overview of Ophthalmic Drug
1.6 Industry Policy Analysis of Ophthalmic Drug
1.7 Industry News Analysis of Ophthalmic Drug
2 Manufacturing Cost Structure Analysis of Ophthalmic Drug
2.1 Bill of Materials (BOM) of Ophthalmic Drug
2.2 BOM Price Analysis of Ophthalmic Drug
2.3 Labor Cost Analysis of Ophthalmic Drug
2.4 Depreciation Cost Analysis of Ophthalmic Drug
2.5 Manufacturing Cost Structure Analysis of Ophthalmic Drug
2.6 Manufacturing Process Analysis of Ophthalmic Drug
2.7 United States Price, Cost and Gross of Ophthalmic Drug 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Ophthalmic Drug Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Ophthalmic Drug Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Ophthalmic Drug Key Manufacturers in 2015
4 Production Analysis of Ophthalmic Drug by Regions, Type, and Applications
4.1 United States Production of Ophthalmic Drug by Regions 2011-2016
4.2 United States Production of Ophthalmic Drug by Type 2011-2016
4.3 United States Sales of Ophthalmic Drug by Applications 2011-2016
4.4 Price Analysis of United States Ophthalmic Drug Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Ophthalmic Drug 2011-2016
5 Consumption Volume and Consumption Value Analysis of Ophthalmic Drug by Regions
5.1 United States Consumption Volume of Ophthalmic Drug by Regions 2011-2016
5.2 United States Consumption Value of Ophthalmic Drug by Regions 2011-2016
5.3 United States Consumption Price Analysis of Ophthalmic Drug by Regions 2011-2016
6 Analysis of Ophthalmic Drug Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Ophthalmic Drug 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Ophthalmic Drug 2014-2015
6.3 Sales Overview of Ophthalmic Drug 2011-2016
6.4 Supply, Consumption and Gap of Ophthalmic Drug 2011-2016
6.5 Import, Export and Consumption of Ophthalmic Drug 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Ophthalmic Drug 2011-2016
7 Analysis of Ophthalmic Drug Industry Key Manufacturers
7.1 Pfizer
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Santen
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Bayer
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 Senju
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 Regeneron
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 Novartis (Alcon)
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
7.7 Allergan (Actavis)
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information
7.8 Roche
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information
7.9 Valeant (including Bausch & Lomb)
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Ophthalmic Drug Product Types
8.5 Market Share Analysis of Different Ophthalmic Drug Price Levels
8.6 Gross Margin Analysis of Different Ophthalmic Drug Applications
9 Marketing Trader or Distributor Analysis of Ophthalmic Drug
9.1 Marketing Channels Status of Ophthalmic Drug
9.2 Traders or Distributors of Ophthalmic Drug with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Ophthalmic Drug
9.4 United States Import, Export and Trade Analysis of Ophthalmic Drug
10 Development Trend of Ophthalmic Drug Industry 2016-2021
10.1 Capacity and Production Overview of Ophthalmic Drug 2016-2021
10.2 Production Market Share by Product Types of Ophthalmic Drug 2016-2021
10.3 Sales and Sales Revenue Overview of Ophthalmic Drug 2016-2021
10.4 United States Sales of Ophthalmic Drug by Applications 2016-2021
10.5 Import, Export and Consumption of Ophthalmic Drug 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Ophthalmic Drug 2016-2021
11 Industry Chain Suppliers of Ophthalmic Drug with Contact Information
11.1 Major Raw Materials Suppliers of Ophthalmic Drug with Contact Information
11.2 Manufacturing Equipment Suppliers of Ophthalmic Drug with Contact Information
11.3 Major Players of Ophthalmic Drug with Contact Information
11.4 Key Consumers of Ophthalmic Drug with Contact Information
11.5 Supply Chain Relationship Analysis of Ophthalmic Drug
12 New Project Investment Feasibility Analysis of Ophthalmic Drug
12.1 New Project SWOT Analysis of Ophthalmic Drug
12.2 New Project Investment Feasibility Analysis of Ophthalmic Drug
13 Conclusion of the United States Ophthalmic Drug Industry 2016 Market Research Report
Figure Picture of Ophthalmic Drug
Table Product Specifications of Ophthalmic Drug
Table Classification of Ophthalmic Drug
Figure United States Sales Market Share of Ophthalmic Drug by Product Types in 2015
Table Applications of Ophthalmic Drug
Figure United States Sales Market Share of Ophthalmic Drug by Applications in 2015
Figure Industry Chain Structure of Ophthalmic Drug
Table United States Industry Overview of Ophthalmic Drug
Table Industry Policy of Ophthalmic Drug
Table Industry News List of Ophthalmic Drug
Table Bill of Materials (BOM) of Ophthalmic Drug
Table Bill of Materials (BOM) Price of Ophthalmic Drug
Table Labor Cost of Ophthalmic Drug
Table Depreciation Cost of Ophthalmic Drug
Table Manufacturing Cost Structure Analysis of Ophthalmic Drug in 2015
Figure Manufacturing Process Analysis of Ophthalmic Drug
Table United States Price Analysis of Ophthalmic Drug 2011-2016 (USD/Unit)
Table United States Cost Analysis of Ophthalmic Drug 2011-2016 (USD/Unit)
Table United States Gross Analysis of Ophthalmic Drug 2011-2016
Table Capacity (Unit) and Commercial Production Date of United States Ophthalmic Drug Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Ophthalmic Drug Manufacturers in 2015
Table R&D Status and Technology Source of United States Ophthalmic Drug Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Ophthalmic Drug Key Manufacturers in 2015
Table United States Production of Ophthalmic Drug by Regions 2011-2016 (Unit)
Table United States Production Market Share of Ophthalmic Drug by Regions 2011-2016
Figure United States Production Market Share of Ophthalmic Drug by Regions in 2014
Figure United States Production Market Share of Ophthalmic Drug by Regions in 2015
Table United States Production of Ophthalmic Drug by Types in 2011-2016 (Unit)
Table United States Production Market Share of Ophthalmic Drug by Type in 2011-2016
Figure United States Production Market Share of Ophthalmic Drug by Type in 2014
Figure United States Production Market Share of Ophthalmic Drug by Type in 2015
Table United States Sales of Ophthalmic Drug by Applications 2011-2016 (Unit)
Table United States Production Market Share of Ophthalmic Drug by Applications 2011-2016
Figure United States Production Market Share of Ophthalmic Drug by Applications in 2014
Figure United States Production Market Share of Ophthalmic Drug by Applications in 2015
Table Price Comparison of United States Ophthalmic Drug Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Ophthalmic Drug 2011-2016
Table United States Consumption Volume of Ophthalmic Drug by Regions 2011-2016 (Unit)
Table United States Consumption Volume Market Share of Ophthalmic Drug by Regions 2011-2016
Figure United States Consumption Volume Market Share of Ophthalmic Drug by Regions in 2014
Figure United States Consumption Volume Market Share of Ophthalmic Drug by Regions in 2015
Table United States Consumption Value of Ophthalmic Drug by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Ophthalmic Drug by Regions 2011-2016
Figure United States Consumption Value Market Share of Ophthalmic Drug by Regions in 2014
Figure United States Consumption Value Market Share of Ophthalmic Drug by Regions in 2015
Table Consumption Price of Ophthalmic Drug by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Ophthalmic Drug 2011-2016 (Unit)
Table United States Capacity Market Share of Major Ophthalmic Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Ophthalmic Drug 2011-2016 (Unit)
Table United States Production Market Share of Major Ophthalmic Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Ophthalmic Drug 2011-2016 (Unit)
Table United States Sales Market Share of Major Ophthalmic Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Ophthalmic Drug 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Ophthalmic Drug Manufacturers 2011-2016
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Ophthalmic Drug 2011-2016
Figure United States Capacity Utilization Rate of Ophthalmic Drug 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Ophthalmic Drug 2011-2016
Figure United States Production Market Share of Major Ophthalmic Drug Manufacturers in 2014
Figure United States Production Market Share of Major Ophthalmic Drug Manufacturers in 2015
Figure United States Sales Market Share of Major Ophthalmic Drug Manufacturers in 2014
Figure United States Sales Market Share of Major Ophthalmic Drug Manufacturers in 2015
Figure United States Sales (Unit) and Growth Rate of Ophthalmic Drug 2011-2016
Table United States Supply, Consumption and Gap of Ophthalmic Drug 2011-2016 (Unit)
Table United States Import, Export and Consumption of Ophthalmic Drug 2011-2016 (Unit)
Table Price of United States Ophthalmic Drug Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Ophthalmic Drug Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Ophthalmic Drug 2011-2016 (M USD)
Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Ophthalmic Drug 2011-2016
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Ophthalmic Drug Picture and Specifications of Pfizer
Table Ophthalmic Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Ophthalmic Drug Capacity (Unit), Production (Unit) and Growth Rate of Pfizer 2011-2016
Figure Ophthalmic Drug Production (Unit) and United States Market Share of Pfizer 2011-2016
Table Pfizer Ophthalmic Drug SWOT Analysis
Table Santen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Ophthalmic Drug Picture and Specifications of Santen
Table Ophthalmic Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Santen 2011-2016
Figure Ophthalmic Drug Capacity (Unit), Production (Unit) and Growth Rate of Santen 2011-2016
Figure Ophthalmic Drug Production (Unit) and United States Market Share of Santen 2011-2016
Table Santen Ophthalmic Drug SWOT Analysis
Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Ophthalmic Drug Picture and Specifications of Bayer
Table Ophthalmic Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2011-2016
Figure Ophthalmic Drug Capacity (Unit), Production (Unit) and Growth Rate of Bayer 2011-2016
Figure Ophthalmic Drug Production (Unit) and United States Market Share of Bayer 2011-2016
Table Bayer Ophthalmic Drug SWOT Analysis
Table Senju Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Ophthalmic Drug Picture and Specifications of Senju
Table Ophthalmic Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Senju 2011-2016
Figure Ophthalmic Drug Capacity (Unit), Production (Unit) and Growth Rate of Senju 2011-2016
Figure Ophthalmic Drug Production (Unit) and United States Market Share of Senju 2011-2016
Table Senju Ophthalmic Drug SWOT Analysis
Table Regeneron Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Ophthalmic Drug Picture and Specifications of Regeneron
Table Ophthalmic Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Regeneron 2011-2016
Figure Ophthalmic Drug Capacity (Unit), Production (Unit) and Growth Rate of Regeneron 2011-2016
Figure Ophthalmic Drug Production (Unit) and United States Market Share of Regeneron 2011-2016
Table Regeneron Ophthalmic Drug SWOT Analysis
Table Novartis (Alcon) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Ophthalmic Drug Picture and Specifications of Novartis (Alcon)
Table Ophthalmic Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis (Alcon) 2011-2016
Figure Ophthalmic Drug Capacity (Unit), Production (Unit) and Growth Rate of Novartis (Alcon) 2011-2016
Figure Ophthalmic Drug Production (Unit) and United States Market Share of Novartis (Alcon) 2011-2016
Table Novartis (Alcon) Ophthalmic Drug SWOT Analysis
Table Allergan (Actavis) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Ophthalmic Drug Picture and Specifications of Allergan (Actavis)
Table Ophthalmic Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Allergan (Actavis) 2011-2016
Figure Ophthalmic Drug Capacity (Unit), Production (Unit) and Growth Rate of Allergan (Actavis) 2011-2016
Figure Ophthalmic Drug Production (Unit) and United States Market Share of Allergan (Actavis) 2011-2016
Table Allergan (Actavis) Ophthalmic Drug SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Ophthalmic Drug Picture and Specifications of Roche
Table Ophthalmic Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2011-2016
Figure Ophthalmic Drug Capacity (Unit), Production (Unit) and Growth Rate of Roche 2011-2016
Figure Ophthalmic Drug Production (Unit) and United States Market Share of Roche 2011-2016
Table Roche Ophthalmic Drug SWOT Analysis
Table Valeant (including Bausch & Lomb) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Ophthalmic Drug Picture and Specifications of Valeant (including Bausch & Lomb)
Table Ophthalmic Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Valeant (including Bausch & Lomb) 2011-2016
Figure Ophthalmic Drug Capacity (Unit), Production (Unit) and Growth Rate of Valeant (including Bausch & Lomb) 2011-2016
Figure Ophthalmic Drug Production (Unit) and United States Market Share of Valeant (including Bausch & Lomb) 2011-2016
Table Valeant (including Bausch & Lomb) Ophthalmic Drug SWOT Analysis
Table Ophthalmic Drug Price by Regions 2011-2016
Table Ophthalmic Drug Price by Product Types 2011-2016
Table Ophthalmic Drug Price by Companies 2011-2016
Table Ophthalmic Drug Gross Margin by Companies 2011-2016
Table Price Comparison of Ophthalmic Drug by Regions 2011-2016 (USD/Unit)
Table Price of Different Ophthalmic Drug Product Types (USD/Unit)
Table Market Share of Different Ophthalmic Drug Price Level
Table Gross Margin of Different Ophthalmic Drug Applications
Table Marketing Channels Status of Ophthalmic Drug
Table Traders or Distributors of Ophthalmic Drug with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Ophthalmic Drug (USD/Unit) in 2015
Table United States Import, Export, and Trade of Ophthalmic Drug (Unit)
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Ophthalmic Drug 2016-2021
Figure United States Capacity Utilization Rate of Ophthalmic Drug 2016-2021
Table United States Ophthalmic Drug Production by Type 2016-2021 (Unit)
Table United States Ophthalmic Drug Production Market Share by Type 2016-2021
Figure United States Production Market Share of Ophthalmic Drug by Type in 2021
Figure United States Sales (Unit) and Growth Rate of Ophthalmic Drug 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Ophthalmic Drug 2016-2021
Figure United States Sales of Ophthalmic Drug by Applications 2016-2021 (Unit)
Table United States Production Market Share of Ophthalmic Drug by Applications 2016-2021
Figure United States Production Market Share of Ophthalmic Drug by Applications in 2021
Table United States Production, Import, Export and Consumption of Ophthalmic Drug 2016-2021 (Unit)
Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Ophthalmic Drug 2016-2021
Table Major Raw Materials Suppliers of Ophthalmic Drug with Contact Information
Table Manufacturing Equipment Suppliers of Ophthalmic Drug with Contact Information
Table Major Players of Ophthalmic Drug with Contact Information
Table Key Consumers of Ophthalmic Drug with Contact Information
Table Supply Chain Relationship Analysis of Ophthalmic Drug
Table New Project SWOT Analysis of Ophthalmic Drug
Table New Project Investment Feasibility Analysis of Ophthalmic Drug
Table Part of Interviewees Record List
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
